Dr Katherine Pumphrey joins Ethics Talk to discuss her article, coauthored with Dr Jessica Hart: “What the COVID-19 Pandemic Teaches Us About Pediatric Iatrogenic Risk.”
Clinicians can support shared decision making by assessing patients’ knowledge, eligibility for screening, and preferences for engagement—active, collaborative, or passive—in the decision making process.
AMA J Ethics. 2015;17(7):601-607. doi:
10.1001/journalofethics.2015.17.7.ecas1-1507.
Isabelle M. Mikell joins Ethics Talk to discuss her article, coauthored with Courtney L. Savage Hoggard and Dr Harald Schmidt: "What Should Be Roles of Federal Clinician Governors in Motivating Equity in Locally Coordinated Triage Protocols?"
Dr Evan Anderson joins Ethics Talk to discuss his article, coauthored with Professor Scott Burris: “Which Skills Are Key to Public Health Leaders’ Success in Crisis Management?”
A hypothetical clinical case discusses patient demand for advanced diagnostics such as MRIs when physicians do not recommend such tests. Better patient education is the suggested approach.
Physicians have a duty to learn the facts and use their medical expertise to allay patients' fears rather than order unnecessary tests when a certain disease or condition receives a great deal of media coverage.
The drug Neurontin is used as an example of why it is permissible for physicians to engage in off-label prescribing, but off-label marketing by pharmaceutical companies is prohibited by the FDA.